Sfoglia per Autore
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis
2016-01-01 Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A
Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients.
2017-01-01 Talamonti, M; Galluzzo, M; van den Reek, J; de Jong, E; Lambert, J; Malagoli, P; Bianchi, L; Costanzo, A
Photo-recall cutaneous reaction to gemcitabine
2017-01-01 D'Adamio, S; Talamonti, M; Bianchi, L; Galluzzo, M
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis
2017-01-01 Galluzzo, M; Talamonti, M; Perino, F; Servoli, S; Giordano, D; Chimenti, S; De Simone, C; Peris, K
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature
2017-01-01 Talamonti, M; D'Adamio, S; Bianchi, L; Galluzzo, M
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.
2017-01-01 Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
2017-01-01 Ventura, A; Mazzeo, M; Gaziano, R; Galluzzo, M; Bianchi, L; Campione, E
Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis
2017-01-01 Galluzzo, M; Talamonti, M; D'Adamio, S; Bianchi, L
Tildrakizumab for treating psoriasis
2017-01-01 Galluzzo, M; D’Adamio, S; Bianchi, L; Talamonti, M
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients.
2017-04-01 Talamonti, M; Galluzzo, M; Servoli, S; D'Adamio, S; Bianchi, L
Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study.
2018-01-01 Talamonti, M; Galluzzo, M; Bernardini, N; Caldarola, G; Persechino, S; Cantoresi, F; Egan, C; Potenza, C; Peris, K; Bianchi, L
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab
2018-01-01 Galluzzo, M; D'Adamio, S; Campione, E; Mazzilli, S; Bianchi, L; Talamonti, M
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients
2018-01-01 Galluzzo, M; D’Adamio, S; Pastorino, R; Angela Andreoli, A; Servoli, S; Bianchi, L; Talamonti, M
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation
2018-01-01 Galluzzo, M; Talamonti, M; De Simone, C; D'Adamio, S; Moretta, G; Tambone, S; Caldarola, G; Fargnoli, M; Peris, K; Bianchi, L
Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections
2018-01-01 Galluzzo, M; D'Adamio, S; Bianchi, L; Talamonti, M
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
2018-01-01 Chimenti, Ms; Ortolan, A; Lorenzin, M; Triggianese, P; Talamonti, M; Costa, L; Caso, F; Favero, M; Teoli, M; Galluzzo, M; Scarpa, R; Punzi, L; Perricone, R; Ramonda, R
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
2018-01-01 Costanzo, A; Bianchi, L; Flori, M; Malara, G; Stingeni, L; Bartezaghi, M; Carraro, L; Castellino, G; Galluzzo, M; Supreme Study, G
A safety evaluation of guselkumab for the treatment of psoriasis
2018-01-01 Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy
2018-08-03 Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
2019-01-01 Signa, S; Campione, E; Rusmini, M; Chiesa, S; Grossi, A; Omenetti, A; Caorsi, R; Viglizzo, Gm; Galluzzo, M; Bianchi, L; Talamonti, M; Orlandi, A; Martini, A; Ceccherini, I; Gattorno, M
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2016 | IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis | Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A | Articolo su rivista | |
1-gen-2017 | Role of HLA- C*06 in clinical response to ustekinumab: evidence from real-life in a large cohort of European patients. | Talamonti, M; Galluzzo, M; van den Reek, J; de Jong, E; Lambert, J; Malagoli, P; Bianchi, L; Costanzo, A | Articolo su rivista | |
1-gen-2017 | Photo-recall cutaneous reaction to gemcitabine | D'Adamio, S; Talamonti, M; Bianchi, L; Galluzzo, M | Articolo su rivista | |
1-gen-2017 | Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis | Galluzzo, M; Talamonti, M; Perino, F; Servoli, S; Giordano, D; Chimenti, S; De Simone, C; Peris, K | Articolo su rivista | |
1-gen-2017 | The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature | Talamonti, M; D'Adamio, S; Bianchi, L; Galluzzo, M | Articolo su rivista | |
1-gen-2017 | HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. | Talamonti, M; Galluzzo, M; Zangrilli, A; Papoutsaki, M; Egan, C; Bavetta, M; Tambone, S; Fargnoli, M; Bianchi, L | Articolo su rivista | |
1-gen-2017 | New insight into the pathogenesis of nail psoriasis and overview of treatment strategies | Ventura, A; Mazzeo, M; Gaziano, R; Galluzzo, M; Bianchi, L; Campione, E | Articolo su rivista | |
1-gen-2017 | Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis | Galluzzo, M; Talamonti, M; D'Adamio, S; Bianchi, L | Articolo su rivista | |
1-gen-2017 | Tildrakizumab for treating psoriasis | Galluzzo, M; D’Adamio, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
1-apr-2017 | Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. | Talamonti, M; Galluzzo, M; Servoli, S; D'Adamio, S; Bianchi, L | Articolo su rivista | |
1-gen-2018 | Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study. | Talamonti, M; Galluzzo, M; Bernardini, N; Caldarola, G; Persechino, S; Cantoresi, F; Egan, C; Potenza, C; Peris, K; Bianchi, L | Articolo su rivista | |
1-gen-2018 | A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab | Galluzzo, M; D'Adamio, S; Campione, E; Mazzilli, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
1-gen-2018 | Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients | Galluzzo, M; D’Adamio, S; Pastorino, R; Angela Andreoli, A; Servoli, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
1-gen-2018 | Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation | Galluzzo, M; Talamonti, M; De Simone, C; D'Adamio, S; Moretta, G; Tambone, S; Caldarola, G; Fargnoli, M; Peris, K; Bianchi, L | Articolo su rivista | |
1-gen-2018 | Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections | Galluzzo, M; D'Adamio, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
1-gen-2018 | Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study | Chimenti, Ms; Ortolan, A; Lorenzin, M; Triggianese, P; Talamonti, M; Costa, L; Caso, F; Favero, M; Teoli, M; Galluzzo, M; Scarpa, R; Punzi, L; Perricone, R; Ramonda, R | Articolo su rivista | |
1-gen-2018 | Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study. | Costanzo, A; Bianchi, L; Flori, M; Malara, G; Stingeni, L; Bartezaghi, M; Carraro, L; Castellino, G; Galluzzo, M; Supreme Study, G | Articolo su rivista | |
1-gen-2018 | A safety evaluation of guselkumab for the treatment of psoriasis | Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M | Articolo su rivista | |
3-ago-2018 | Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy | Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M | Articolo su rivista | |
1-gen-2019 | Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab | Signa, S; Campione, E; Rusmini, M; Chiesa, S; Grossi, A; Omenetti, A; Caorsi, R; Viglizzo, Gm; Galluzzo, M; Bianchi, L; Talamonti, M; Orlandi, A; Martini, A; Ceccherini, I; Gattorno, M | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile